Judge Blocks Colorado Amgen Drug Price Cap

A US judge halted a Colorado state panel's move to cap the price of Amgen's blockbuster drug Enbrel. This ruling prevents the state government from setting a price ceiling for the rheumatoid arthritis medication, a win for pharmaceutical companies pushing back on federal and state drug price controls.